What’s Keeping Targeted, Personalized Medicine from Being Successful? (0:33)
Personalized medications face enormous regulatory hurdles. In this video, HealthMaker Laura Esserman, MD, director of the Carol Franc Buck Breast Care Center, UCSF, explains how difficult it is to get medications approved.
Read Transcript
If we want personalized medicine to be successful, we have to be aware of the bigger context of that too. It cost $2 billion and 15 years to get a drug approved. How are we going to get personalized medicines through as we start to learn that cancer is made of both smaller and smaller subsets? Even breast cancers many disease.
So we have to figure out how to get the right drug, to the right patient, at the right time and to do it in a cost-effective way, affordable and effective. That's what we want our healthcare to be and we all are.
Laura Esserman, MD, MBA, is a surgeon and breast cancer oncology specialist at the UCSF Carol Franc Buck Breast Care Center. She talks about breast cancer prevention and screening, as well as the latest advances in breast cancer treatment.
